Drugs & Targets FDA approves Keytruda + chemo for HER2-negative gastric or GEJ cancer November 17, 2023Vol.49 No.43
Drugs & Targets FDA approves Edison histotripsy device to treat liver tumors November 17, 2023Vol.49 No.43
Drugs & Targets FDA approves Fruzaqla for previously treated metastatic CRC November 10, 2023Vol.49 No.42
Drugs & Targets FDA approves neoadjuvant/ adjuvant Keytruda for resectable NSCLC October 20, 2023Vol.49 No.39
